Skip to main content
. 2021 Spring;14(2):154–159.

Table 3.

HBV recurrence rate after transplant (positive DNA) in Lamivudine and Tenofovir groups during the follow up period

Variables HBV Recurrence in 1 month (n, %) HBV Recurrence in 6 months (n, %) HBV Recurrence in 12 months (n, %) HBV Recurrence after 12 months (n, %)
Lamivudine group 2 (2.1%) 1 (1.31%) 2 (3.2%) 3 (5.3%)
Tenofovir group 1 (0.5%) 4 (1.9%) 4 (2.1%) 5 (2.7%)
P. value 0.22* 0.1* 0.64* 0.34*

* Fisher’s Exact Test